Adenocarcinoma of the Prostate
113
1
9
71
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
52 trials with published results (46%)
Research Maturity
71 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
16.8%
19 terminated out of 113 trials
78.9%
-7.6% vs benchmark
8%
9 trials in Phase 3/4
73%
52 of 71 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 71 completed trials
Clinical Trials (113)
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Radiation and Androgen Ablation for Prostate Cancer
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer
Prospective Prostate Cancer and Patient-reported Outcomes Registry
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma
Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer